Nature Communications (Mar 2022)

An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression

  • Ting Shen,
  • Ting Ni,
  • Jiaxuan Chen,
  • Haitao Chen,
  • Xiaopin Ma,
  • Guangwen Cao,
  • Tianzhi Wu,
  • Haisheng Xie,
  • Bin Zhou,
  • Gang Wei,
  • Hexige Saiyin,
  • Suqin Shen,
  • Peng Yu,
  • Qianyi Xiao,
  • Hui Liu,
  • Yuzheng Gao,
  • Xidai Long,
  • Jianhua Yin,
  • Yanfang Guo,
  • Jiaxue Wu,
  • Gong-Hong Wei,
  • Jinlin Hou,
  • De-Ke Jiang

DOI
https://doi.org/10.1038/s41467-022-28861-0
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 15

Abstract

Read online

The role of enhancer variants in hepatocellular carcinoma (HCC) predisposition remains unknown. Here, the authors perform a genome-wide survey of HCC-susceptible enhancer variants in 11,958 individuals, identify rs73613962 within the intronic region of PRMT7 and find that PRMT7 upregulation predisposes to HCC.